Events
GRASP brings patients and researchers together for small-group conversations that make cancer science more accessible, collaborative, and deeply informed by patient experience.
- This event has passed.
Poster Walkthroughs are virtual small group sessions where advocates and researchers discuss posters from cancer conferences.
ASCO26 Group 5B: Treatment Strategies for Brain Metastases in HER2+ Breast Cancer
June 12 @ 2:00 pm - 3:30 pm
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting is a global conference highlighting the latest advances in cancer research and care. GRASP provides a unique opportunity for advocates and clinical researchers to join the conversation through Poster Walkthroughs.
Register Below
This ASCO26 Poster Walkthrough group will explore key findings from the following posters:
Poster #1055: Safety and efficacy of ZN-A-1041, a highly blood-brain barrier (BBB)–permeable HER2 tyrosine kinase inhibitor (TKI), + trastuzumab deruxtecan (T-DXd) or pertuzumab-trastuzumab (PH) in HER2-positive metastatic breast cancer (HER2+ mBC): Phase Ic expansion results from the ZN-A-1041-101-US trial.
Poster #1051: Real-world brain metastasis outcomes with T-DXd versus tucatinib-based therapy in second-line HER2-positive metastatic breast cancer.
Track: Breast Cancer—Metastatic | Subtrack: HER2-Positive (HER2+) | Keywords: Brain metastasis, Trial in progress, Real-world outcomes
